+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains

The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains

International Journal of Antimicrobial Agents 20(5): 384-386

This study evaluated the in vitro effects of the combination of a carbapenem (imipenem or meropenem) with a quinolone (ciprofloxacin or levofloxacin) using a microbroth dilution chequerboard technique and multidrug-resistant Pseudomonas aeruginosa strains. The ciprofloxacin and meropenem combination was only synergistic against 2 strains (6.2%) and ciprofloxacin and imipenem against 1 strain (3.1%). Levofloxacin and imipenem or meropenem were not synergistic for against any strain. None of the combinations showed an antagonistic effect.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 011484168

Download citation: RISBibTeXText

PMID: 12431875

DOI: 10.1016/s0924-8579(02)00192-9

Related references

In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant Pseudomonas aeruginosa Strains. Chemotherapy 49(6): 294-297, 2003

In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. ChemoTherapy 49(6): 294-297, 2003

In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa. Bmc Infectious Diseases 16(1): 444, 2016

Comparative in vitro activity of meropenem against pseudomonas aeruginosa and pseudomonas maltophilia isolated from cystic fibrosis patients including imipenem resistant strains. Abstracts of the General Meeting of the American Society for Microbiology 91: 3, 1991

Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin. European Journal of Clinical Microbiology and Infectious Diseases 34(2): 317-323, 2015

Comparison of the in vitro activity of meropenem and doripenem against Pseudomonas aeruginosa and multidrug-resistant Enterobacteriaceae. Acta Clinica Belgica 65(6): 451, 2011

In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa. Microbial Drug Resistance 20(6): 550-554, 2014

Additive effect of gyrA, parC and gyrB mutations on ciprofloxacin resistance in strains of Pseudomonas aeruginosa susceptible or resistant to imipenem. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 83, 1998

Comparative antibacterial activities of meropenem , imipenem , ceftazidime , piperacillin/tazobactam , ciprofloxacin and tobramycin , singly and in combination against resistant and susceptible isolates of Pseudomonas aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 104, 1995

In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa. Journal of Antibiotics 50(2): 135-138, 1997

In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa. Pakistan Journal of Pharmaceutical Sciences 26(5): 1041-1044, 2013

In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia. Journal of ChemoTherapy 3(3): 143-146, 1991

In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa. Journal of ChemoTherapy 8(5): 358-364, 1996

In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Journal of Antimicrobial ChemoTherapy 33(5): 949-958, 1994

Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Antimicrobial Agents and ChemoTherapy 42(4): 953-955, 1998